Table 1.
Policies on reporting authors’, reviewers’, and editors’ conflict of interests in rheumatology journals*
| N | Abbreviated Journal Titles | SJR quartile | H index | 2-Y JIF | Authors | Reviewers | Editors |
|---|---|---|---|---|---|---|---|
| 1 |
Ann Rheum Dis |
Q1 |
132 |
9.111 |
+ |
+ |
+ |
| 2 |
Arthritis Rheum |
Q1 |
211 |
7.477 |
+ |
+ |
+ |
| 3 |
Arthritis Res Ther |
Q1 |
84 |
4.302 |
+ |
+ |
+ |
| 4 |
Arthritis Care Res |
Q1 |
82 |
3.731 |
+ |
+ |
+ |
| 5 |
Nat Rev Rheumatol |
Q1 |
52 |
9.745 |
+ |
+ |
+ |
| 6 |
Rheumatology |
Q1 |
106 |
4.212 |
+ |
+ |
+ |
| 7 |
Semin Arthritis Rheum |
Q1 |
73 |
3.806 |
+ |
+ |
+ |
| 8 |
Clin Exp Rheumatol |
Q1 |
62 |
2.655 |
+ |
NA |
NA |
| 9 |
Rheum Dis Clin North Am |
Q1 |
61 |
2.096 |
+ |
+ |
NA |
| 10 |
Curr Rheumatol Rep |
Q1 |
37 |
- |
+ |
NA |
NA |
| 11 |
BMC Musculoskelet Dis |
Q1 |
41 |
1.875 |
+ |
+ |
+ |
| 12 |
Joint Bone Spine |
Q2 |
43 |
2.748 |
+ |
NA |
NA |
| 13 |
Musculoskelet Care |
Q2 |
12 |
- |
NA |
NA |
NA |
| 14 |
Rheumatol int |
Q2 |
43 |
2.214 |
+ |
NA |
NA |
| 15 |
Bull NYU Hosp Jt Dis |
Q2 |
26 |
- |
+ |
NA |
NA |
| 16 |
Biologics |
Q2 |
12 |
- |
+ |
+ |
NA |
| 17 |
J Clin Rheumatol |
Q2 |
29 |
1.183 |
NA |
NA |
NA |
| 18 |
Pediatr Rheumatol |
Q2 |
10 |
1.47 |
+ |
+ |
+ |
| 19 |
Int J Rheum Dis |
Q2 |
12 |
1.65 |
+ |
NA |
NA |
| 20 |
Reumatismo |
Q2 |
13 |
- |
+ |
NA |
NA |
| 21 |
Open Rheumatol J |
Q2 |
3 |
- |
+ |
NA |
NA |
| 22 |
Int J Clin Rheumatol |
Q2 |
6 |
- |
+ |
+ |
+ |
| 23 |
Acta Reumatol Port |
Q3 |
10 |
0.695 |
+ |
NA |
NA |
| 24 |
Rev Bras Ruematol |
Q3 |
10 |
- |
+ |
NA |
NA |
| 25 |
Int J Adv Rheumatol |
Q3 |
3 |
- |
NA |
NA |
NA |
| 26 |
Curr Rheumatol Rev |
Q3 |
7 |
- |
+ |
NA |
NA |
| 27 |
Autoimmunity Highlights |
Q3 |
3 |
- |
+ |
NA |
NA |
| 28 |
Reumatol Clin |
Q3 |
7 |
- |
+ |
NA |
NA |
| 29 |
J Musculoskelet Pain |
Q3 |
25 |
0.328 |
+ |
NA |
NA |
| 30 |
Z Rheumatol |
Q3 |
31 |
0.450 |
+ |
NA |
NA |
| 31 |
Rheumatol Rep |
Q3 |
1 |
- |
+ |
NA |
NA |
| 32 |
Turk J Rheumatol |
Q3 |
3 |
0.172 |
+ |
NA |
NA |
| 33 |
Rev Rhum Monograph |
Q3 |
3 |
- |
+ |
NA |
NA |
| 34 |
Open Access Rheumatol |
Q4 |
3 |
- |
+ |
+ |
NA |
| 35 |
Ceska Revmatol |
Q4 |
6 |
- |
NA |
NA |
NA |
| 36 |
Reumatologia |
Q4 |
7 |
- |
+ |
NA |
NA |
| 37 |
Ther Adv Muskuloskelet Dis |
Q4 |
2 |
- |
+ |
NA |
NA |
| 38 |
Open Arthritis J |
Q4 |
0 |
- |
+ |
NA |
NA |
| 39 |
Indian J Rheumatol |
Q4 |
5 |
- |
+ |
NA |
NA |
| 40 |
Akt Rheumatol |
Q4 |
9 |
0.097 |
+ |
NA |
NA |
| 41 |
Rev Rhum (Edition Francaise) |
Q4 |
28 |
- |
+ |
NA |
NA |
| 42 |
Semin Fund Esp Reumatol |
Q4 |
2 |
- |
+ |
NA |
NA |
| 43 | Reumatol Clin Supl | Q4 | 3 | - | NA | NA | NA |
*Data are obtained from the SCImago Journal and Country Rank database (SCImago Journal Rank [SJR] quartiles and journal H index values for 2013) and the Journal Citation Reports 2013 (2-Year Journal Impact Factors [2-Y JIF]). NA – not available.